Stock screenerAll disclosures →
EDGAR →
INAB
Conviction 20HealthcareScan · Mon, Aug 10, 2026INAB$0.9700-0.88%
ResistanceSupportVol 14Vol MA14 62.78K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.9700
Change-0.88%
Gap+0.18%
Rel volume2.31×
Avg volume61.72K
Avg $ vol69.46K
SMA 201.15
SMA 501.33
SMA 2001.67
Price vs 50-27.14%
Price vs 200-41.85%
MA stackbearish
50/200 cross—
Supertrenddown · 1.18
RSI (14)26
MACD hist-0.01
MACD cross—
Stoch %K / %D20 / 20
ADX (14)42
+DI / −DI9 / 34
RSI divergence—
MACD divergence—
ATR %+7.41%
ADR %5.73%
52w high2.59
52w low0.9600
From 52w high-62.55%
Above 52w low+1.04%
New 52w highNo
SqueezeOff
Bollinger width53.58%
%B0.21
Donchian pos12.45%
Donchian high1.46
Donchian low0.9000
AVWAP (52w high)1.61
vs AVWAP high-39.75%
AVWAP (52w low)0.9698
vs AVWAP low+0.02%
OBV trendDown
Chaikin MF (20)-0.29
Today vs 20d2.31×
Avg vol (14d)62.78K
Avg vol (20d)61.72K
Avg $ vol (20d)69.46K
Market cap9.56M
RS 3m (vs SPY)-44.53%
RS 6m (vs SPY)-62.61%
RS line new highNo
Trend template0/8
Technical rank5.3
1 week+1.04%
1 month-27.07%
3 months-38.61%
6 months-51.26%
1 year-54.88%
YTD-60.57%
P/E-0.49
P/B0.52
P/S—
P/FCF—
EPS-4.44
Div yield—
ROE-105.87%
ROA-89.40%
Debt/Eq—
Current8.21
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth36.13%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-8.57M
Revenue—
Net income-4.78M
Gross profit—
Free cash flow—
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out9.85M
Employees18
ListedFri, Jul 30, 2021
Free float6.96M
Float %70.7%
Short interest20.79K
Days to cover0.4d
Short volume45.5%
Squeeze score21 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank5.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.52
Support0.9200
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in INAB
No recent disclosed trades by Congress in INAB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in INAB · 8 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
FAIRBAIRN EMILY Director · Common Stock · 2026-05-27 | Gift | 724.64K | $0 | 2026-05-27 | 2026-05-29 |
FAIRBAIRN EMILY Director · Common Stock · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-29 |
Ho William Tai-Wei CEO · Employee Stock Option (right to buy) · 2026-05-09 | Grant | 154.5K | $0 | 2026-05-09 | 2026-05-12 |
FAIRBAIRN EMILY Director · Stock Option (right to buy) · 2026-05-09 | Grant | 22K | $0 | 2026-05-09 | 2026-05-12 |
Epperly Corinne Director · Stock Option (right to buy) · 2026-05-09 | Grant | 22K | $0 | 2026-05-09 | 2026-05-12 |
Rochlin Kate President and COO · Employee Stock Option (right to buy) · 2026-05-09 | Grant | 60K | $0 | 2026-05-09 | 2026-05-12 |
Lamb Lawrence EVP and CSO · Employee Stock Option (right to buy) · 2026-05-09 | Grant | 54K | $0 | 2026-05-09 | 2026-05-12 |
Graff Jeremy R. Director · Stock Option (right to buy) · 2026-05-09 | Grant | 22K | $0 | 2026-05-09 | 2026-05-12 |
McCall Patrick CHIEF FINANCIAL OFFICER · Employee Stock Option (right to buy) · 2026-05-09 | Grant | 56.25K | $0 | 2026-05-09 | 2026-05-12 |
Greenwood Luba Director · Stock Option (right to buy) · 2026-05-09 | Grant | 22K | $0 | 2026-05-09 | 2026-05-12 |
SEC filings
EDGAR filings in INAB · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.